Delivery Order SPE2DB20D1109-SPE2DB23FP08V
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the delivery of Buprenorphine 20 mcg/hr Patch 4s, a specialty pharmaceutical product. The contract, valued at $1,060.77, has an ultimate completion date of April 21, 2023. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Buprenorphine 20 MCG/HR Patch 4S. The $1,946.84 firm fixed-price contract has a completion date of June 21, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a delivery order issued under a federal Indefinite Delivery Contract (IDC) by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $4,601.04 firm fixed-price award is for the supply of 4,565,705,592 units of Buprenorphine 15 MCG/HR Patches. The contract has a period of performance through September 9, 2024 and does not have a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distributors in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,130.90 to AmerisourceBergen Drug Corp for Buprenorphine 20 mcg/hr patches (quantity of 4 units) on October 23, 2025, with an ultimate completion date of October 24, 2025. The award was made without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order as a child contract action under its larger...
- This federal contract award is for the delivery of Buprenorphine 15 MCG/HR Patch 4S, a pain management medication, to the Defense Logistics Agency (DLA). The $2,422.28 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 1, 2021, with a completion date of November 2, 2021. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,535.19, is for the delivery of Buprenorphine 20 MCG/HR Patch 4S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of October 27, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award, with ID SPE2DX15D3306|SPE2DX25FADSZ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,532.24 firm fixed-price delivery order is for the supply of 4566640887 BUTRANS 20 MCG/HR PATCH 4S, a pain management medication. The contract has an ultimate completion date of December 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of BUPRENORPHINE 20 MCG/HR PATCH 4S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 17, 2024 with a ceiling value of $1,211.98. The contract is a Delivery Order under a Firm Fixed Price arrangement and has an ultimate completion date of October 18, 2024. This award is not designated as a set-aside...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,427.27, is for the supply of Buprenorphine 20 mcg/hr Patch to the government. The contract is a firm fixed-price delivery order with a completion date of April 30, 2024. There is no set-aside designation for this contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
- The Defense Logistics Agency Troop Support Medical awarded a $602,930 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4,561,624 units of 20 mcg/hr buprenorphine patches. The one-day contract has a period of performance from July 27 through July 28, 2023, with all work taking place in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for transdermal buprenorphine patches will support DLA's...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP08VDelivery Order
This federal contract award SPE2DB20D1109|SPE2DB23FP08V was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,255.16 firm fixed-price delivery order is for the supply of 4560861778 BUPRENORPHINE 10 MCG/HR PATCH 4S, a medication used for pain management. The contract has an ultimate completion date of May 9, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 5/8/23 |